SCHEMBL5317366

SCHEMBL5317366

C[C@H]1CNCCN1c1ccc(C(F)(F)F)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 4/20 0.46
HTR2A P28223 3/20 0.46
KCNH2 Q12809 1/20 0.46
SGPL1 O95470 1/20 0.44
HDAC8 Q9BY41 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
HDAC1 Q13547 1/20 0.43
KDM4E B2RXH2 3/20 0.42
ABL1 P00519 1/20 0.42
LMNA P02545 1/20 0.42
CNR2 P34972 2/20 0.41
CNR1 P21554 1/20 0.41
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
APAF1 O14727 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GAA P10253 1/20 0.41
CXCR3 P49682 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL230341 1.00 HTR2C (0.46) HTR2CHTR2AKCNH2SGPL1HDAC8
SCHEMBL1028259 1.00 HTR2C (0.46) HTR2CHTR2AKCNH2SGPL1HDAC8
Hydrochloric Acid SCHEMBL28966672 0.99 HTR2C (0.45) HTR2CHTR2AKCNH2SGPL1HDAC8
Hydrochloric Acid SCHEMBL28966675 0.99 HTR2C (0.45) HTR2CHTR2AKCNH2SGPL1HDAC8
Tert-Butyl Formate SCHEMBL27747676 0.89 HTR2C (0.46) HTR2CHTR2AKCNH2SGPL1HDAC8
SCHEMBL17128127 0.85 HTR2C (0.39) HTR2CHTR2AKCNH2HDAC8HDAC6
SCHEMBL17519369 0.83 NR1H2 (0.49) HTR2CHTR2AHDAC8HDAC6HDAC1
Hydrochloric Acid SCHEMBL28982903 0.83 KDM4E (0.41) HTR2CHTR2AHDAC8HDAC6HDAC1
SCHEMBL21336969 0.82 HTR2C (0.39) HTR2CHTR2AKCNH2HDAC8HDAC6
SCHEMBL23744328 0.82 ROCK2 (0.43) HTR2CHTR2AKCNH2CXCR3HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007076318-A2 CAMPHOR-DERIVED CXCR3 ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2007-07-05 WO disclosed